drugset / Trial / NCT00483028

A Randomized, Placebo-Controlled Trial to Examine the Efficacy of Oral Donepezil in Subjects With MCI

NCT00483028

Completed 38 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

To purpose of this study is to estimate the effect of donepezil on Neuropsychological Testing (NPT) and brain Proton Magnetic Resonance Spectroscopy.

Timeline

Start
2004-06
Primary completion
Completion
2007-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Donepezil Small molecule 5 mg Oral

Indications